FirstRanker.com
A Firstranker's choice
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
--- Content provided by FirstRanker.com ---
JUNE 2012CARDIOLOGY
PAPER-1
Time: 3 hours CARD/J/12/05/1
Max. Marks : 100
--- Content provided by FirstRanker.com ---
Attempt all questions in order.
Each question carries 10 marks.
- Describe coagulation pathways and indicate where the anticoagulants interfere. 5+5
- Describe the anatomy of triangle of Koch's. Explain the mechanism of paroxysmal junctional reciprocating tachycardia. How is it treated? 3+4+3
- What are hypercoagulable states? What are the laboratory tests for their diagnosis? Outline management of hypercoagulable state. 3+3+4
- Describe invasive and non-invasive evaluation of pulmonary arterial hypertension. How will you assess reversibility? 3+3+4
- What is coronary flow reserve? Describe its clinical significance. 5+5
- Discuss genetics & manifestation of ventricular non-compaction. 5+5
- Describe embryogenesis of conotruncal anomalies. Classify double outlet right ventricle and correlate with manifestations. 4+3+3
- Describe Fick principle and estimation of cardiac output by this principle. 5+5
- Discuss the principles and cardiovascular applications of Optical Coherence Tomography (OCT). 5+5
- Discuss genetics of long QT syndrome & its clinical relevance. 5+5
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL
--- Content provided by FirstRanker.com ---
A Firstranker's choiceFINAL EXAM
JUNE 2012
Time: 3 hours
CARDIOLOGY
--- Content provided by FirstRanker.com ---
PAPER- IIMax. Marks : 100
Attempt all questions in order.
Each question carries 10 marks.
- Outline the manifestation, evaluation, diagnosis and management of HFNEF (Heart Failure with Normal Ejection Fraction). 2+3+3+2
- Describe etiopathogenesis and evaluation of left main coronary disease. What is the current status of its management? 3+3+4
- Describe in brief the role of left atrial appendage in thromboembolism. Outline current status of left atrial appendage occluder devices. 4+6
- Describe general principles, indications and regimens for infective endocarditis prophylaxis. 3+3+4
- What are the causes and manifestation of loss of capture in cardiac pacing? Describe its diagnosis and management. 2+2+3+3
- What is the etiopathogenesis, manifestation and management of ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy)? 2+4+4
- Describe anti-thrombotic therapy for non-cardiac surgery in post coronary stenting. 10
- What is peripartum cardiomyopathy? Discuss its risk factors, treatment and prognosis. 3+3+3+1
- Discuss etiology and management of pacemaker implant infection. 5+5
- What is stent thrombosis? Discuss its etiopathogenesis and diagnostic criteria. 2+4+4
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
NATIONAL BOARD OF EXAMINATIONS
--- Content provided by FirstRanker.com ---
CARD/J/12/05/11POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL
FirstRanker.com
Firstranker's choice
--- Content provided by FirstRanker.com ---
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2012
CARDIOLOGY
PAPER- II
Time: 3 hours CARD/J/12/05/11I
--- Content provided by FirstRanker.com ---
Max. Marks : 100Attempt all questions in order.
Each question carries 10 marks.
- Describe ‘COURAGE Trial'. What is the contribution of the trial to clinical practice? 4+6
- Discuss the role of MRI in ischemic cardiomyopathy, hypertrophic cardiomyopathy & arrhythmogenic right ventricular dysplasia. 3+3+4
- What are bioabsorbable stents? Outline their current status. 3+7
- What is micro T wave alterans? What is their role in cardiac arrhythmogenesis? 3+7
- Discuss current status of fetal cardiac intervention. 10
- Discuss current status of PFO (patent foramen ovale) in cardiovascular disease and PFO closure. 6+4
- Discuss indications and current status of tissue heart valves. 3+7
- What are drug eluting balloons? What is their present status in interventions? 5+5
- What are leadless pacemakers? What is the current status of leadless permanent cardiac pacing devices? 5+5
- Discuss the role of renal denervation in treatment of hypertension 10
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL
--- Content provided by FirstRanker.com ---
This download link is referred from the post: DNB 2013 June Previous Question Papers-(Diplomate of National Board) Under NBE
--- Content provided by FirstRanker.com ---